Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2021-11-30 2021-11-04
Drug Identification Number 02266342 02266342
Brand name FLUMAZENIL INJECTION FLUMAZENIL INJECTION
Common or Proper name Flumazenil Injection 0.1 mg/mL MD Vial 5 mL Flumazenil Injection 0.1 mg/mL MD Vial 5 mL
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients FLUMAZENIL FLUMAZENIL
Strength(s) 0.1MG 0.1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN) (See additional packaging sizes) (See additional packaging sizes)
Additional packaging sizes 5 mL 5 mL
ATC code V03AB V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-12-01 2021-11-03
Estimated end date Unknown Unknown
Actual end date
Shortage status Anticipated shortage Actual shortage
Tier 3 Status No No
Company comments On 50% allocation On 100% allocation
Health Canada comments